Novel and validated titrimetric method for determination of selected angiotensin-II-receptor antagonists in pharmaceutical preparations and its comparison with UV spectrophotometric determination
Open Access
- 31 December 2012
- journal article
- Published by Elsevier BV in Journal of Pharmaceutical Analysis
- Vol. 2 (6), 470-477
- https://doi.org/10.1016/j.jpha.2012.03.009
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Development of a solid phase extraction procedure for HPLC–DAD determination of several angiotensin II receptor antagonists in human urine using mixture designTalanta, 2007
- A liquid chromatography/tandem mass spectrometry method for the simultaneous quantification of valsartan and hydrochlorothiazide in human plasmaJournal of Chromatography B, 2007
- Development and validation of a method for quantitative determination of valsartan in human plasma by liquid chromatography-tandem mass spectrometryJournal of Pharmaceutical and Biomedical Analysis, 2007
- Determination of telmisartan in human blood plasma: Part I: Immunoassay developmentAnalytica Chimica Acta, 2006
- Biocompatible in-tube solid-phase microextraction coupled to HPLC for the determination of angiotensin II receptor antagonists in human plasma and urineJournal of Chromatography B, 2005
- Comparison of UV- and second derivative-spectrophotometric and LC methods for the determination of valsartan in pharmaceutical formulationJournal of Pharmaceutical and Biomedical Analysis, 2002
- Significance of angiotensin type 1 receptor blockade: why are angiotensin II receptor blockers different?The American Journal of Cardiology, 1999
- AT1-receptor blockers in hypertension and heart failure: clinical experience and future directionsEuropean Heart Journal, 1999
- Overview of angiotensin II-receptor antagonistsThe American Journal of Cardiology, 1998
- Comparison of liquid chromatography, capillary electrophoresis and super-critical fluid chromatography in the determination of Losartan Potassium drug substance in Cozaar® tabletsJournal of Pharmaceutical and Biomedical Analysis, 1996